CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 242 filers reported holding CONMED CORP in Q3 2020. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,409,712 | -16.0% | 43,725 | +13.2% | 0.27% | -12.8% |
| Q2 2023 | $5,250,813 | +5.9% | 38,640 | -59.5% | 0.31% | -0.9% |
| Q1 2023 | $4,960,219 | +116721.0% | 95,422 | +99.2% | 0.32% | +6.4% |
| Q4 2022 | $4,246 | -99.9% | 47,906 | -1.2% | 0.30% | +4.6% |
| Q3 2022 | $3,886,000 | -11.5% | 48,471 | +5.7% | 0.28% | +1.8% |
| Q2 2022 | $4,391,000 | -36.5% | 45,853 | -1.5% | 0.28% | -22.7% |
| Q1 2022 | $6,916,000 | +10.0% | 46,558 | +5.0% | 0.36% | +18.8% |
| Q4 2021 | $6,285,000 | -10.7% | 44,335 | -17.6% | 0.30% | -13.6% |
| Q3 2021 | $7,041,000 | -1.5% | 53,820 | +3.5% | 0.35% | -1.7% |
| Q2 2021 | $7,148,000 | +7.7% | 52,011 | +2.3% | 0.36% | +3.2% |
| Q1 2021 | $6,639,000 | +16.5% | 50,840 | -0.1% | 0.35% | +22.6% |
| Q4 2020 | $5,701,000 | -17.1% | 50,904 | -41.7% | 0.28% | -18.9% |
| Q3 2020 | $6,873,000 | +7.4% | 87,365 | -1.7% | 0.35% | +2.3% |
| Q2 2020 | $6,400,000 | – | 88,903 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hood River Capital Management LLC | 448,126 | $38,346,000 | 1.80% |
| HealthCor Management, L.P. | 455,190 | $38,951,000 | 1.51% |
| Champlain Investment Partners, LLC | 1,452,360 | $124,278,000 | 1.04% |
| J. Goldman & Co LP | 162,771 | $13,928,000 | 0.96% |
| Granahan Investment Management | 189,925 | $16,252,000 | 0.80% |
| PURA VIDA INVESTMENTS, LLC | 50,000 | $4,279,000 | 0.65% |
| OAK RIDGE INVESTMENTS LLC | 102,797 | $8,797,000 | 0.61% |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 78,722 | $6,736,000 | 0.54% |
| MOODY ALDRICH PARTNERS LLC | 23,834 | $2,039,000 | 0.52% |
| 361 CAPITAL LLC | 30,901 | $2,644,000 | 0.47% |